Symbols

HCM

Hutchmed·NASDAQ

--(--)

Market Open: --

--(--)

Pre-Market: --

Signals Analysis

Bullish signal 1

Bearish signal 1

Consensus Rating "Sell"

MACD Golden Cross

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About HCM

Hutchmed (China) Limited

A developer of drugs for the treatment of oncology and immunological diseases for global market

Industry

Pharmaceutical

Established Date

12/18/2000

Listing Date

03/17/2016

Exchange

NASDAQ Stock Exchange

Full-time Employees

1,780

Fiscal Year Ends

12-31

Website

www.hutch-med.com

Security Type

Depository Receipts (Ordinary Shares)

Office address

48th Floor, heung Kong Center, 2 Queen’s Road Central, Hong Kong

Business

Hutchison Pharmaceuticals (China) Co., Ltd. (the 'Company ') and its subsidiaries (collectively the' Group ') are principally engaged in the research and development, production and marketing of pharmaceuticals. The Group has R&D facilities and production plants in the People's Republic of China (' China ') and sells its products mainly in China (including Hong Kong and Macau). In addition, the Group has established international operations in the United States and Europe.

Introduction

Hutchison Pharmaceuticals (China) Co., Ltd. is an investment holding company principally engaged in the manufacture and sale of pharmaceuticals. The company operates its business primarily through two divisions. The Tumor Immunology business segment is engaged in the discovery, development and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immune diseases. R & D includes R&D activities covering drug discovery, development, production and regulatory functions. Listed products include the invoiced sales, promotion, production and distribution of drugs developed through R&D activities. Other business segments are engaged in other commercialization businesses, including the sales, promotion, production and distribution of other prescription drugs and health products.